CSL has made a great FDA success as show below. Not IMU but posted out of interest.
Quote - "Australian biotech giant CSL will bring the first gene therapy for haemophilia B to market in the United States after gaining regulatory approval for a new drug called Hemgenix. CSL confirmed on Wednesday that the US Food and Drug Administration has granted approval for the therapy, which it has been developing since inking a deal worth $US655 million with US biotech UniQure back in 2020.
Because gene therapies are designed as one-off treatments that replace regular treatments across a patient’s lifetime, they often come with steep price tags. CSL will list Hemgenix at $US3.5 million ($5.3 million), making it one of the most expensive single treatments in the history of the United States."
- Forums
- ASX - By Stock
- Media Thread
CSL has made a great FDA success as show below. Not IMU but...
-
- There are more pages in this discussion • 7,634 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.2¢ | 5.3¢ | 5.2¢ | $17.46K | 334.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 1032283 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 1322324 | 33 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 1025742 | 0.052 |
39 | 3925326 | 0.051 |
73 | 6188895 | 0.050 |
18 | 2391726 | 0.049 |
21 | 798435 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 1322324 | 33 |
0.054 | 2181963 | 16 |
0.055 | 3918380 | 16 |
0.056 | 2701070 | 13 |
0.057 | 446030 | 6 |
Last trade - 10.51am 26/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online